The immune checkpoint programmed death 1 (PD‐1) receptor and its ligand PD‐L1 (Iwai et al, 2002) are often activated in cancer and play an important role in mediating escape from immune control by inhibiting cytotoxic T‐cell function (Tolaney et al, 2015). Here, CD274 is linked to cancer.